Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Reina

Showing results (1-10 of 274) with videos related to

Pageof 28
Sort By:
Lancet (London, England)|October 24, 1992
Resistance to fluoroquinolones in Salmonella non-typhi and Campylobacter sppJ Reina
Enfermedades Infecciosas Y Microbiologia Clinica|June 1, 1997
[Mechanisms of antiviral resistance among the herpesvirus group]J Reina
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|February 19, 2022
[The Victoria and Yamagata Lineages of Influenza B Viruses, unknown and undervalued]J Reina
Revista Clinica Espanola|June 10, 2021
[Possible effect of the "original antigenic sin" in vaccination against new variants of SARS-CoV-2]J Reina
Vacunas|June 23, 2020
[The SARS-CoV-2, a new pandemic zoonosis that threatens the world]J Reina
Enfermedades Infecciosas Y Microbiologia Clinica|May 3, 2001
[Is rapid and specific virological detection of influenza really necessary?]J Reina
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|April 20, 1999
[Prophylaxis and treatment of respiratory infections caused by influenza virus types A and B]J Reina
Medicina Clinica|February 5, 1994
[Antibiotic resistance detected in the different groups of enteropathogens in Palma de Mallorca]J Reina
Revista Clinica Espanola|September 26, 2021
Possible effect of the "original antigenic sin" in vaccination against new variants of SARS-CoV-2J Reina
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|April 27, 2021
[Plitidepsin, an inhibitor of the cell elongation factor eEF1a, and molnupiravir an analogue of the ribonucleoside cytidine, two new chemical compounds with intense activity against SARS-CoV-2]J Reina
Pageof 28

Showing results (1-10 of 274) with videos related to

Sort By:
Pageof 28
Lancet (London, England)|October 24, 1992
Resistance to fluoroquinolones in Salmonella non-typhi and Campylobacter sppJ Reina
Enfermedades Infecciosas Y Microbiologia Clinica|June 1, 1997
[Mechanisms of antiviral resistance among the herpesvirus group]J Reina
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|February 19, 2022
[The Victoria and Yamagata Lineages of Influenza B Viruses, unknown and undervalued]J Reina
Revista Clinica Espanola|June 10, 2021
[Possible effect of the "original antigenic sin" in vaccination against new variants of SARS-CoV-2]J Reina
Vacunas|June 23, 2020
[The SARS-CoV-2, a new pandemic zoonosis that threatens the world]J Reina
Enfermedades Infecciosas Y Microbiologia Clinica|May 3, 2001
[Is rapid and specific virological detection of influenza really necessary?]J Reina
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|April 20, 1999
[Prophylaxis and treatment of respiratory infections caused by influenza virus types A and B]J Reina
Medicina Clinica|February 5, 1994
[Antibiotic resistance detected in the different groups of enteropathogens in Palma de Mallorca]J Reina
Revista Clinica Espanola|September 26, 2021
Possible effect of the "original antigenic sin" in vaccination against new variants of SARS-CoV-2J Reina
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|April 27, 2021
[Plitidepsin, an inhibitor of the cell elongation factor eEF1a, and molnupiravir an analogue of the ribonucleoside cytidine, two new chemical compounds with intense activity against SARS-CoV-2]J Reina
Pageof 28